Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours

Clinical Endocrinology

Volumn 49, Issue 1, 1998, Pages 53-61

  Fernandez Real J M ^a   Ricart Engel, W ^a   Simo R ^b   Salinas, I ^c   Webb, S M ^d  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL TUMOR; ADULT; AGED; ARTICLE; CARBOHYDRATE METABOLISM; CARBOHYDRATE TOLERANCE; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; HYDROCORTISONE RELEASE; HYPERINSULINEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 14444270341     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00437.x     Document Type: Article

References (36)

1. Anderson, W.A. & Kissane, J.M. (1977) Adrenal tumours. In Pathology, 7th edn Mosby, St Louis, pp 1671-1674.
2. Bergman, R.N., Prager, R., Volund, A. & Olefsky, J.M. (1987) Equivalence of the insulin sensitivity index in man derived by the minimal model method and euglycaemic glucose clamp. American Journal of Clinical Investigation, 79, 790-800.
3. Buffington, C.K., Givens, J.R. & Kitabchi, A.E. (1994) Enhanced adrenocortical activity as a contributing factor to diabetes in hyprandrogenic women. Metabolism, 43, 584-590.
4. Cederholm, J. & Wibell, L. (1990) Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Research in Clinical Practice, 10, 167-175.
5. Departement de Sanitat. Generalitat de Catalunya. (1998) The prevalence of non-insulin-dependent diabetes mellitus in Catalonia. Butlleti Epidemiològic de Catalunya (in press).
6. Ditkoff, E.C., Fruzzetti, F., Chang, L., Stancyzk, F.Z. & Lobo, R.A. (1995) The impact of estrogen on adrenal androgen sensitivity and secretion in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 80, 603-607.
7. Fernández-Real, J.M., Ricart, W. & Simó, R. (1994) Pre-clinical Cushing's syndrome: Report of three cases and literature review. Hormone Research, 41, 230-235.
8. Hedeland, H., Östberg, G. & Hökfelt, B. (1968) On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Medica Scandinavica, 184, 211-214.
9. Jaresch, S., Kornely, E., Kley, H.-K. & Schlaghecke, R. (1992) Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 74, 685-689.
10. Jindal, R.M., Sidner, R.A., Hughes, D., Pescovitz, M.D., Leapman, S.B., Milgrom, M.L., Lumeng, L. & Filo, R.S. (1996) Metabolic problems in recipients of liver transplants. Clinical Transplantation, 10, 213-217.
11. Klink, D. & Estrich, K. (1964) Plasma insulin concentration in Cushing's syndrome and thyrotoxicosis. Clinical Research, 12, 354-358.
12. Kloos, R.T., Gross, M.D., Francis, I.R., Korobkin, M. & Shapiro, B. (1995) Incidentally discovered adrenal masses. Endocrine Review, 16, 460-484.
13. Kramer, R.E., Buster, J.E. & Andersen, R.N. (1990) Differential modulation of ACTH-stimulated cortisol and androstenedione secretion by insulin. Journal of Steroid Biochemistry, 36, 33-42.
14. Lentle, B.C. & Thomas, J.P. (1964) Adrenal function and the complications of diabetes mellitus. The Lancet, ii, 544-549.
15. Modigliani, E., Strauch, G. & Luton, J.P. (1970) Effect of glucose and arginine on insulin secretion in Cushing's syndrome. Diabetologia, 6, 8-12.
16. Moghetti, P., Castello, R., Negri, C., Tosi, F., Spiazzi, G.G., Bron, E., Balducci, R., Toscano, V. & Muggeo, M. (1996) Insulin infusion amplifies 17α-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: Apparent relative impairment of 17,20-lyase activity. Journal of Clinical Endocrinology and Metabolism, 81, 881-886.
17. National Diabetes Data Group. (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes, 28, 1039-1057.
18. O'Rahilly, S., Gray, H., Humphreys, P.J., Krook, A., Polonsky, K.S., White, A., Gibson, S., Taylor, K. & Carr, C. (1995) Processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. The New England Journal of Medicine, 333, 1386-1390.
19. Osella, G., Terzolo, M., Borretta, G., Magro, P., Ali, A., Piovesan, A., Paccotti, P. & Angeli, A. (1994) Endocrine evaluation of incidentally discovered adrenal masses (Incidentalomas). Journal of Clinical Endocrinology and Metabolism, 79, 1532-1539.
20. Perley, N. & Kipnis, D.M. (1966) Effect of glucocorticoids on plasma insulin. The New England Journal of Medicine, 274, 1237-1241.
21. Plotz, C.M., Knowlton, A.I. & Ragan, C. (1952) The natural history of Cushing's syndrome. The American Journal of Medicine, 13, 597-614.
22. Reaven, G.M. (1988) The Banting Lecture 1988: role of insulin resistance in human disease. Diabetes, 37, 1595-1607.
23. Reincke, M., Nieke, J., Krestin, G.P., Saeger, W., Allolio, B. & Winkelmann, W. (1992) Preclinical Cushing's syndrome in adrenal 'incidentalomas': comparison with adrenal Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 75, 826-832.
24. Reincke, M., Faßnacht, M., Väth, S., Mora, P. & Allolio, B. (1996) Adrenal incidentalomas: A manifestation of the metabolic syndrome? Endocrine Research, 22, 757-761.
25. Ricart, W. & Fernández-Real, J.M. (1995) Hyperinsulinemia and hyperglycemia in incidental adrenal adenoma. Endocrinologia, 42 (suppl), 18-19.
26. Ricart, W. & Fernández-Real, J.M. (1996) Carbohydrate metabolism and ACTH secretion as tools of study of incidental adrenal adenomas. Endocrinologia, 43, 2-5.
27. Ross, N.S. & Aron, D.C. (1990) Hormonal evaluation of the patient with an incidentally discovered adrenal mass. The New England Journal of Medicine, 323, 1401-1405.
28. Roy, M., Collier, B. & Roy, A. (1990) Hypothalamic-pituitary-adrenal axis dysregulation among diabetic patients. Psychiatry Research, 31, 31-37.
29. Russi, S., Blumenthal, H.T. & Gray, S.H. (1945) Small adenomas of the adrenal cortex in hypertension and diabetes. Archives of Internal Medicine, 76, 284-291.
30. Sacerdote, A.S. (1995) Adrenal androgens and NIDDM. Diabetes Care, 18, 278-279.
31. Sacket-Lundeen, L., Nicolau, G.Y., Lakatua, D.J., Bogdan, C., Petrescu, E., Jachimowicz, A. & Haus, E. (1987) Peculiarities of the endocrine time structure in noninsulin-dependent adult-onset (type II) diabetes mellitus. Progress in Clinical and Biological Research, 227AP, 467-482.
32. Seppel, T. & Schlaghecke, R. (1994) Augmented 17-α-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas'). Clinical Endocrinology, 41, 445-451.
33. Tsigos, C., Young, R.J. & White, A. (1993) Diabetic neuropathy is associated with increased activity of the hypothalamic-pituitary adrenal axis. Journal of Clinical Endocrinology and Metabolism, 76, 554-558.
34. Urbanic, R.C. & George, J.M. (1981) Cushing's Disease - 18 Years' Experience. Medicine, 60, 14-24.
35. Van den Berg, G., Frölich, M., Veldhuis, J.D. & Roelfsema, F. (1995) Combined amplification of the pulsatile and basal modes of adrenocorticotropin and cortisol secretion in patients with Cushing's disease: Evidence for decreased responsiveness of the adrenal glands. Journal of Clinical Endocrinology and Metabolism, 80, 3750-3757.
36. Vermes, I., Steinmetz, E., Schoorl, J., Van der Veen, E.A. & Tilders, F.J.H. (1985) Increased plasma levels of immunoreactive β-endorphin and corticotropin in non-insulin-dependent diabetes. The Lancet, ii, 725-726.